Real-world efficacy of ramucirumab plus paclitaxel with or without nivolumab in advanced gastric and gastroesophageal junction cancers. (2026). Annals of Medical Research, 33(3), 091-098. http://www.annalsmedres.org/index.php/aomr/article/view/4905